Vishuo Biomedical develops precision medicine products and laboratory information systems.
Established in 2014 and based in Singapore, Vishuo Biomedical develops tools for disease diagnosis and treatment, including knowledge bases, pharmacogenomics solutions, precision oncology and disease risk prediction. Its BioLIMS system helps laboratories track samples and link patient, experimental and report data. It raised RMB 40 million in series A funding in June 2015 from Anjie Investment and Anlongmed Investment, followed by funding from Anlongmed Investment in August 2017.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in